169 related articles for article (PubMed ID: 22237625)
1. Pocket proteins suppress head and neck cancer.
Shin MK; Pitot HC; Lambert PF
Cancer Res; 2012 Mar; 72(5):1280-9. PubMed ID: 22237625
[TBL] [Abstract][Full Text] [Related]
2. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus.
Braakhuis BJ; Snijders PJ; Keune WJ; Meijer CJ; Ruijter-Schippers HJ; Leemans CR; Brakenhoff RH
J Natl Cancer Inst; 2004 Jul; 96(13):998-1006. PubMed ID: 15240783
[TBL] [Abstract][Full Text] [Related]
3. High incidence of female reproductive tract cancers in FA-deficient HPV16-transgenic mice correlates with E7's induction of DNA damage response, an activity mediated by E7's inactivation of pocket proteins.
Park JW; Shin MK; Lambert PF
Oncogene; 2014 Jun; 33(26):3383-91. PubMed ID: 24013229
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus type 16 E6 and E7 oncoproteins act synergistically to cause head and neck cancer in mice.
Jabbar S; Strati K; Shin MK; Pitot HC; Lambert PF
Virology; 2010 Nov; 407(1):60-7. PubMed ID: 20797753
[TBL] [Abstract][Full Text] [Related]
5. Identification of biomarkers that distinguish human papillomavirus (HPV)-positive versus HPV-negative head and neck cancers in a mouse model.
Strati K; Pitot HC; Lambert PF
Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14152-7. PubMed ID: 16959885
[TBL] [Abstract][Full Text] [Related]
6. Role of Rb-dependent and Rb-independent functions of papillomavirus E7 oncogene in head and neck cancer.
Strati K; Lambert PF
Cancer Res; 2007 Dec; 67(24):11585-93. PubMed ID: 18089787
[TBL] [Abstract][Full Text] [Related]
7. A mouse model for human anal cancer.
Stelzer MK; Pitot HC; Liem A; Schweizer J; Mahoney C; Lambert PF
Cancer Prev Res (Phila); 2010 Dec; 3(12):1534-41. PubMed ID: 20947489
[TBL] [Abstract][Full Text] [Related]
8. The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation.
Zhang B; Chen W; Roman A
Proc Natl Acad Sci U S A; 2006 Jan; 103(2):437-42. PubMed ID: 16381817
[TBL] [Abstract][Full Text] [Related]
9. DEK promotes HPV-positive and -negative head and neck cancer cell proliferation.
Adams AK; Hallenbeck GE; Casper KA; Patil YJ; Wilson KM; Kimple RJ; Lambert PF; Witte DP; Xiao W; Gillison ML; Wikenheiser-Brokamp KA; Wise-Draper TM; Wells SI
Oncogene; 2015 Feb; 34(7):868-77. PubMed ID: 24608431
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of SMG-1 in HPV-positive head and neck squamous cell carcinoma due to promoter hypermethylation correlates with improved survival.
Gubanova E; Brown B; Ivanov SV; Helleday T; Mills GB; Yarbrough WG; Issaeva N
Clin Cancer Res; 2012 Mar; 18(5):1257-67. PubMed ID: 22247495
[TBL] [Abstract][Full Text] [Related]
11. Persistence of high-grade cervical dysplasia and cervical cancer requires the continuous expression of the human papillomavirus type 16 E7 oncogene.
Jabbar SF; Abrams L; Glick A; Lambert PF
Cancer Res; 2009 May; 69(10):4407-14. PubMed ID: 19435895
[TBL] [Abstract][Full Text] [Related]
12. Inactivating all three rb family pocket proteins is insufficient to initiate cervical cancer.
Shin MK; Sage J; Lambert PF
Cancer Res; 2012 Oct; 72(20):5418-27. PubMed ID: 22942253
[TBL] [Abstract][Full Text] [Related]
13. High incidence of HPV-associated head and neck cancers in FA deficient mice is associated with E7's induction of DNA damage through its inactivation of pocket proteins.
Park JW; Shin MK; Pitot HC; Lambert PF
PLoS One; 2013; 8(9):e75056. PubMed ID: 24086435
[TBL] [Abstract][Full Text] [Related]
14. pRb and CyclinD1 Complement p16 as Immunohistochemical Surrogate Markers of HPV Infection in Head and Neck Cancer.
Dreyer JH; Hauck F; Barros MHM; Niedobitek G
Appl Immunohistochem Mol Morphol; 2017; 25(5):366-373. PubMed ID: 26657876
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus type 16 E7 oncoprotein can induce abnormal centrosome duplication through a mechanism independent of inactivation of retinoblastoma protein family members.
Duensing S; Münger K
J Virol; 2003 Nov; 77(22):12331-5. PubMed ID: 14581569
[TBL] [Abstract][Full Text] [Related]
16. cGAS-STING responses are dampened in high-risk HPV type 16 positive head and neck squamous cell carcinoma cells.
Shaikh MH; Bortnik V; McMillan NA; Idris A
Microb Pathog; 2019 Jul; 132():162-165. PubMed ID: 31054871
[TBL] [Abstract][Full Text] [Related]
17. Retinoblastoma Protein Is Required for Epstein-Barr Virus Replication in Differentiated Epithelia.
Myers JE; Schaal DL; Nkadi EH; Ward BJH; Bienkowska-Haba M; Sapp M; Bodily JM; Scott RS
J Virol; 2023 Feb; 97(2):e0103222. PubMed ID: 36719239
[TBL] [Abstract][Full Text] [Related]
18. Deficiencies in the Fanconi anemia DNA damage response pathway increase sensitivity to HPV-associated head and neck cancer.
Park JW; Pitot HC; Strati K; Spardy N; Duensing S; Grompe M; Lambert PF
Cancer Res; 2010 Dec; 70(23):9959-68. PubMed ID: 20935219
[TBL] [Abstract][Full Text] [Related]
19. Critical roles for non-pRb targets of human papillomavirus type 16 E7 in cervical carcinogenesis.
Balsitis S; Dick F; Dyson N; Lambert PF
Cancer Res; 2006 Oct; 66(19):9393-400. PubMed ID: 17018593
[TBL] [Abstract][Full Text] [Related]
20. Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype.
Rampias T; Pectasides E; Prasad M; Sasaki C; Gouveris P; Dimou A; Kountourakis P; Perisanidis C; Burtness B; Zaramboukas T; Rimm D; Fountzilas G; Psyrri A
Ann Oncol; 2013 Aug; 24(8):2124-31. PubMed ID: 23406730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
